⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL981554 | 0.82 | CYP2A6 (0.41) | — | |
| SCHEMBL11322723 | 0.79 | CTRC (0.49) | — | |
| SCHEMBL968257 | 0.77 | MAPT (0.47) | — | |
| SCHEMBL31179739 | 0.76 | — | — | |
| SCHEMBL3125154 | 0.76 | — | — | |
| SCHEMBL11780788 | 0.76 | ELANE (0.38) | — | |
| SCHEMBL11774947 | 0.76 | MAPT (0.50) | — | |
| SCHEMBL9027254 | 0.73 | PDE4D (0.40) | — | |
| SCHEMBL19679869 | 0.70 | MAPT (0.35) | — | |
| Viridepyronone SCHEMBL18270619 | 0.70 | ALDH1A1 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119331139-A | Catalyst component for olefin polymerization, catalyst and application thereof | 中国石油天然气股份有限公司 | 2025-01-21 | — | — | CN | claimed |
| CN-119331142-A | Catalyst component for olefin polymerization, catalyst and application thereof | 中国石油天然气股份有限公司 | 2025-01-21 | — | — | CN | claimed |
| CN-119331139-A | Catalyst component for olefin polymerization, catalyst and application thereof | 中国石油天然气股份有限公司 | 2025-01-21 | — | — | CN | disclosed |
| CN-119331142-A | Catalyst component for olefin polymerization, catalyst and application thereof | 中国石油天然气股份有限公司 | 2025-01-21 | — | — | CN | disclosed |
| US-9034850-B2 | Gonadotropin releasing hormone receptor antagonist, preparation method thereof and pharmaceutical composition comprising the same | SK CHEMICALS CO., LTD. (KR) | 2015-05-19 | — | — | US | disclosed |
| US-20130137661-A1 | Gonadotropin Releasing Hormone Receptor Antagonist, Preparation Method Thereof And Pharmaceutical Composition Comprising The Same | SK CHEMICALS CO. LTD. (KR) | 2013-05-30 | — | — | US | disclosed |
| WO-2011062437-A2 | GONADOTROPIN RELEASING HORMONE RECEPTOR ANTAGONISTS, MANUFACTURING METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | 에스케이케미칼주식회사 (KR) | 2011-05-26 | — | — | WO | disclosed |
| US-20110014504-A1 | LITHIUM SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2011-01-20 | — | — | US | disclosed |
| US-20080311478-A1 | Lithium Secondary Battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2008-12-18 | — | — | US | disclosed |
| EP-1892789-A1 | LITHIUM SECONDARY BATTERY | Mitsubishi Chemical Corporation (JP) | 2008-02-27 | — | — | EP | disclosed |
| EP-0892774-A4 | PYRONIN ANTIBACTERIALS, PROCESS AND NOVEL INTERMEDIATES THERETO | ANADYS PHARMACEUTICALS INC (US) | 2001-10-04 | — | — | EP | disclosed |
| EP-1043990-A1 | PYRONIN ANTIBACTERIALS, PROCESS AND NOVEL INTERMEDIATES THERETO | Scriptgen Pharmaceuticals, Inc. (US) | 2000-10-18 | — | — | EP | disclosed |
| US-6127551-A | 4-HYDROXY-6-ETHYOXYCARBONYLALKENYL-2H-PYRAN-2-ONE IS ACYLATED WITH PROPIONYL CHLORIDE TO FORM A KETONE ADDUCT, FOLLOWED BY BASE-CATALYZED ALDOL TO FROM A PYRONE ALDOL; MESYLATION, FORM A PYRONE KETONE; AND CURTIUS SEQUENCE TO FORM MYXOPYRONIN | SCRIPTGEN PHARMACEUTICALS, INC. (US) | 2000-10-03 | — | — | US | disclosed |
| US-6090953-A | PREPARING A MYXOPYRONIN | SCRIPTGEN PHARMACEUTICALS, INC. (US) | 2000-07-18 | — | — | US | disclosed |
| WO-2000015626-A1 | PROCESS FOR THE PREPARATION OF INTERMEDIATES FOR PYRONIN ANTIBACTERIALS | ANADYS PHARMACEUTICALS, INC. (US) | 2000-03-23 | — | — | WO | disclosed |
| US-6022983-A | PREPARING A MYXOPYRONIN | SCRIPTGEN PHARMACEUTICALS, INC. (US) | 2000-02-08 | — | — | US | disclosed |
| US-5986111-A | CONDENSATION OF ALDEHYDE WITH PYRONE TO FORM ADDUCT, OXIDATION AND SAPONIFICATION | SCRIPTGEN PHARMACEUTICALS, INC. (US) | 1999-11-16 | — | — | US | disclosed |
| WO-1999034793-A1 | PYRONIN ANTIBACTERIALS, PROCESS AND NOVEL INTERMEDIATES THERETO | SCRIPTGEN PHARMACEUTICALS, INC. (US) | 1999-07-15 | — | — | WO | disclosed |
| EP-0892774-A2 | PYRONIN ANTIBACTERIALS, PROCESS AND NOVEL INTERMEDIATES THERETO | SCRIPTGEN PHARMACEUTICALS, INC. (US) | 1999-01-27 | — | — | EP | disclosed |
| WO-1997034569-A2 | PYRONIN ANTIBACTERIALS, PROCESS AND INTERMEDIATES | SCRIPTGEN PHARMACEUTICALS, INC. (US) | 1997-09-25 | — | — | WO | disclosed |